New York Life Investment Management LLC Has $5.19 Million Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

New York Life Investment Management LLC trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 0.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,594 shares of the medical research company’s stock after selling 278 shares during the period. New York Life Investment Management LLC’s holdings in Agilent Technologies were worth $5,185,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Robeco Schweiz AG raised its holdings in shares of Agilent Technologies by 1.6% in the 4th quarter. Robeco Schweiz AG now owns 1,156,536 shares of the medical research company’s stock valued at $155,369,000 after purchasing an additional 18,677 shares during the period. SRN Advisors LLC bought a new stake in shares of Agilent Technologies in the 4th quarter valued at about $737,000. Sitrin Capital Management LLC raised its holdings in shares of Agilent Technologies by 0.5% in the 4th quarter. Sitrin Capital Management LLC now owns 35,189 shares of the medical research company’s stock valued at $4,727,000 after purchasing an additional 170 shares during the period. Lake Street Advisors Group LLC raised its holdings in shares of Agilent Technologies by 7.1% in the 4th quarter. Lake Street Advisors Group LLC now owns 3,529 shares of the medical research company’s stock valued at $475,000 after purchasing an additional 234 shares during the period. Finally, FFT Wealth Management LLC raised its holdings in shares of Agilent Technologies by 19.7% in the 4th quarter. FFT Wealth Management LLC now owns 3,516 shares of the medical research company’s stock valued at $472,000 after purchasing an additional 578 shares during the period.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link.

Agilent Technologies Stock Up 0.6 %

Shares of A opened at $127.83 on Friday. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35. The firm’s 50 day moving average is $140.64 and its 200-day moving average is $139.14. The stock has a market capitalization of $36.47 billion, a PE ratio of 29.39, a P/E/G ratio of 3.64 and a beta of 1.07. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.58%. The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.78%. Agilent Technologies’s dividend payout ratio is 22.76%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on A shares. Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a report on Monday, December 9th. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $135.00 to $145.00 in a report on Monday, February 10th. Robert W. Baird lowered their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday. Sanford C. Bernstein lowered their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a report on Tuesday, November 26th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.